Clinical Trials Directory

Trials / Completed

CompletedNCT05277038

Clonidine is Better Than Zopiclone for Insomnia Treatment in Chronic Pain Patients

Status
Completed
Phase
Study type
Observational
Enrollment
150 (actual)
Sponsor
Salem Anaesthesia Pain Clinic · Academic / Other
Sex
All
Age
20 Years – 99 Years
Healthy volunteers
Accepted

Summary

A prospective observational crossover study of 160 consenting adult patients who underwent pain management. For insomnia treatment, each patient ingested different prescribed doses of Zopiclone or Clonidine on alternate nights. Each patient used a special validated sleep diary to collect data including pain score, sleep scores, sleep duration, sleep medication dose, and adverse effects. Each patient completed the diary for 3 continuous weeks. Pain was measured using the numeric pain rating scale. Sleep score was measured using the Likert sleep scale. A change in the pain or sleep scores by 2-points was considered significant.

Detailed description

Objectives: Chronic pain is associated with insomnia. The objective of this clinical study is to compare the efficacy and safety of different prescribed doses of Zopiclone and Clonidine; for the management of insomnia in patients with chronic pain. Methods: A prospective observational crossover study of 160 consenting adult patients who underwent pain management. For insomnia treatment, each patient ingested different prescribed doses of Zopiclone or Clonidine on alternate nights. Each patient used a special validated sleep diary to collect data including pain score, sleep scores, sleep duration, sleep medication dose, and adverse effects. Each patient completed the diary for 3 continuous weeks. Pain was measured using the numeric pain rating scale. Sleep score was measured using the Likert sleep scale. A change in the pain or sleep scores by 2-points was considered significant. Data were analyzed with IBM® SPSS® Statistics 25 (IBM Corp, Armonk, NY); using Student's t-test, ANOVA, Pearson Chi-square test, and regression analysis. P-value \<0.05 was considered significant.

Conditions

Interventions

TypeNameDescription
DRUGClonidine 0.1mg pillRoutine prescription for insomnia
DRUGClonidine 0.2mg pillRoutine prescription for insomnia
DRUGZopiclone 3.75mg pillRoutine prescription for insomnia
DRUGZopiclone 7.5mg pillRoutine prescription for insomnia

Timeline

Start date
2022-03-01
Primary completion
2022-11-05
Completion
2022-11-05
First posted
2022-03-14
Last updated
2022-11-18

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05277038. Inclusion in this directory is not an endorsement.